Can light therapy and eye drops stop Kids' myopia from worsening?

NCT ID NCT04923841

Completed Disease control Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether bright light therapy, special glasses that create myopic defocus, low-dose atropine eye drops, or combinations of these can slow the progression of nearsightedness in schoolchildren. A total of 577 children aged 7-12 with myopia participated. The goal was to see which approach best controls eye growth and reduces the need for stronger prescriptions over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: atropine 0.01% eye drops
What this could lead to: If successful, this could provide a practical combination therapy to slow worsening nearsightedness in children, reducing their risk of severe eye problems later in life.
What could go wrong: The trial is completed but results are not yet widely reported, so the true benefit is unknown. The interventions require daily use, which may be hard for children to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Centre for Myopia Research, The Hong Kong Polytechnic University and Department of Ophthalmology, The University of Hong Kong

Hong Kong, No postcode, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.